33.98% of Tripura has COVID-19 antibody in them, shows sero survey
Survey:
Epi surveillance
Prevalence
Dataset Records for Prevalence
Displaying 101 - 150 of 5348
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint
GHDx Entry last modified on: May 12, 2022
Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II
Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase
Survey:
Individual - Interview
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October
GHDx Entry last modified on: May 12, 2022
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2020, Phase 4 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares -
Andhra Pradesh Sero Survey Show Nearly 20% of State’s Population Exposed to Covid-19
Survey:
Cross-sectional - Epi surveillance - Urban only
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares -
20% of Andhra Exposed to Covid, Sero-survey Finds, Exposure Highest Where Case Tally Lowest
Survey:
Cross-sectional - Epi surveillance - Urban only
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint
GHDx Entry last modified on: Oct 5, 2022
Mexico National Health and Nutrition Survey (ENSANUT) about COVID-19 2020
Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19, ENSANUT Continua COVID-19
Epi surveillance:
Household - Interview - Urban-rural representative
Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria. Preprint
Scientific literature:
Epi surveillance
Assam's Sero-survey found 23.7 per cent Seroprevalence in the State
Survey:
Epi surveillance
Serum-epidemiological Survey of SARS-CoV-2, City of Maputo (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Maputo (InCOVID 2020) - Resultados Preliminares -
Press Briefing: Sero Survey Delhi
Survey:
Cross-sectional - Urban only
Over 56% of Delhi has Covid-19 Antibodies: Health Minister Satyendar Jain on 5th Serosurvey
Survey:
Urban only
Serum-epidemiological Survey of SARS-CoV-2, City of Quelimane (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Quelimane (InCOVID 2020) - Resultados Preliminares -
[Preliminary results of the National Health and Nutrition Survey COVID-19]
Communiqué 255: Resultados preliminares de la Encuesta Nacional de Salud y Nutrición COVID-19
Survey:
Cross-sectional - Epi surveillance - Household - Individual - Nationally representative
Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020
GHDx Entry last modified on: Jun 17, 2021
United States - Ohio Prevalence of Current and Past COVID-19 in Adults July 2020
Prevalence of Current and Past COVID-19 in Ohio Adults
Survey:
Epi surveillance - Individual
Epidemiological and Serological Surveillance of COVID-19 in Pune City, Technical Report, August 16, 2020
Technical Report (dt August 16, 2020): Epidemiological and Serological Surveillance of COVID-19 in Pune City
Survey:
Epi surveillance
SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020. Preprint
GHDx Entry last modified on: Mar 14, 2022
Assam’s First Sero-survey Gets Underway, Here’s Everything You Need To Know About It
GHDx Entry last modified on: Aug 1, 2022
Norway SARS-CoV-2 Seroprevalence Residual Sera Follow-up Survey July-September 2020
Seroprevalence of SARS-CoV-2 in the Norwegian population measured in residual sera collected in late summer 2020
Survey:
Epi surveillance - Individual
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey
GHDx Entry last modified on: Feb 10, 2022
The Burden of COVID-19 Infection in a Rural Tamil Nadu Community. Preprint
GHDx Entry last modified on: Mar 14, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Pemba (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Pemba (InCOVID 2020) - Resultados Preliminares -
Anti-SARS-CoV-2 IgG seroprevalence study among blood donors in the Republic of Srpska: a 30-day survey
Studija seroprevalencije anti-SARS-CoV-2 IgG kod davalaca krvi u Republici Srpskoj: 30-dnevno ispitivanje
Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic. Preprint
GHDx Entry last modified on: Oct 6, 2022
SARS-CoV-2 seroprevalence and characteristics of post-infection immunity in a general population cohort study in Catalonia, Spain. Preprint
GHDx Entry last modified on: May 12, 2022
Presence of antibodies against SARS-CoV-2 in the district area Rinkeby-Kista, Stockholm, 22–24 June 2020
Förekomsten av antikroppar mot SARS-CoV-2 i stadsdelsområdet Rinkeby-Kista, Stockholm, 22–24 juni 2020
Survey:
Community - Cross-sectional - Exam - Urban only
Covid antibodies found in 97% of Delhi residents
Survey:
Epi surveillance
Montenegro Institute of Public Health COVID-19 Dashboard June 2020
GHDx Entry last modified on: May 12, 2022
Sero-prevalence of SARS-CoV-2 Antibody Among Adults in the General Population in Diredawa, Ethiopia. Preprint
GHDx Entry last modified on: Sep 13, 2022
Canada - Quebec COVID-19 First Wave Blood Donor Seroprevalence Study 2020
Étude De Séroprévalence Des Anti-Sras-Cov-2 Chez Les Donneurs De Sang D’héma-Québec, Vers La Fin De La Première Vague De Covid-19
Survey:
Epi surveillance
In May 2020, 4.5% of the population of metropolitan France had developed antibodies against SARS-CoV-2
Survey:
Longitudinal
Fernando de Noronha: how an island controlled the community transmission of COVID-19 in Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
Increase in SARS-CoV-2 seroprevalence in healthy blood donors after the second wave of COVID-19 pandemic in South-Eastern Italy: evidence for asymptomatic young individuals as potential virus spreaders. Preprint
GHDx Entry last modified on: Mar 14, 2022
India - Kerala COVID 19 Sero Surveillance Report August - September 2021
COVID 19 Sero Surveillance Report
Survey:
Cross-sectional - Epi surveillance
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
GHDx Entry last modified on: Jun 17, 2021
The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia
GHDx Entry last modified on: Jun 17, 2021
COVID-19: around 35 000 people have been tested
GHDx Entry last modified on: Feb 10, 2022
Prevalence of SARS-CoV-2 Antibodies from a one-year National Serosurveillance of Kenyan Blood Transfusion Donors. Preprint
GHDx Entry last modified on: Mar 14, 2022
COVID-19 at a metropolitan region: public polices and social vulnerability within an iniquity context. Preprint
COVID-19 em uma Região Metropolitana: vulnerabilidade social e políticas públicas em contextos de desigualdades
Canada COVID-19 Seroprevalence Report - April 2020 to January 2021
COVID-19 Public Seroprevalence Report April 2020 to January 2021
Epi surveillance:
Nationally representative
Strategies for Infection Control and Prevalence of Anti-SARS-CoV-2 IgG Antibodies in 4,554 Employees of a University Hospital in Munich, Germany. Preprint
GHDx Entry last modified on: Mar 14, 2022
Chile Epidemiological Report on COVID-19 Disease 2020-2022
Informe Epidemiológico Enfermedad por SARS-CoV-2 (COVID-19)
Subscribe